Gsk-1292263 clinical trials
Also written GSK1292263.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses gsk-1292263 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- GSK1292263
- 3
Studies by the year they started
4 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gsk-1292263 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With AtorvastatinCompletedPhase 2GlaxoSmithKlineNCT01218204Written as 100mg GSK1292263
- A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and PharmacodynamicsCompletedPhase 2GlaxoSmithKlineNCT01119846Written as GSK1292263
- A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263CompletedPhase 2GlaxoSmithKlineNCT01128621Written as GSK1292263
- A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy SubjectsCompletedPhase 1GlaxoSmithKlineNCT01101568Written as GSK1292263
Codes
What other systems call gsk-1292263 · ClinicalTrials.gg INT006479
- Wikidata Q27287662gsk-1292263One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27287662 | gsk-1292263 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.